학술논문
4SC-202+Pembrolizumab: "SENSITIZE" the tumor to overcome PD1-refractoriness and increase efficacy of checkpoint inhibition in patients with advanced melanoma
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
16100387